Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Head & Neck 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Sarcoma, Kaposi 1Nasopharyngeal Neoplasms 1Lymphoma, Primary Effusion 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1

Interventions

Rituximab 1371Cyclophosphamide 1297Vincristine 662Doxorubicin 583Etoposide 525Prednisone 504Cytarabine 481fludarabine 462Methotrexate 441Dexamethasone 411fludarabine phosphate 396Lenalidomide 347Filgrastim 342Bendamustine Hydrochloride 274Radiotherapy 266venetoclax 255ibrutinib 249Peripheral Blood Stem Cell Transplantation 233Melphalan 229obinutuzumab 228Granulocyte Colony-Stimulating Factor 212Bortezomib 204Gemcitabine 201Busulfan 186Whole-Body Irradiation 185Mycophenolic Acid 174Tacrolimus 164Specimen Handling 161Calcium Dobesilate 150Magnetic Resonance Spectroscopy 149

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × fialuridine × Lymphoid × Clear all
NCT00982449 2018-09-17

124I-FIAU Imaging in EBV and KSHV Associated Cancers

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Completed
12 enrolled
GastrointestinalHead & NeckLymphoidSarcoma

Hodgkin Disease, Lymphoma, Non-Hodgkin, Nasopharyngeal Neoplasms, Sarcoma, Kaposi, Stomach Neoplasms, Lymphoma, Primary Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡